✦ LIBER ✦

1001-8 Long-term results of ISAR-REACT: A randomized trial evaluating Abciximab in patients with elective percutaneous coronary intervention after pretreatment with a high loading dose of clopidogrel

✍ Scribed by Helmut Schuhlen; Adnan Kastrati; Julinda Mehilli; Josef Dirschinger; Franz Dotzer; Jurrien ten Berg; Franz-Josef Neumann; Peter B Berger; Albert Schomig

Book ID: 119547819
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 46 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(04)90007-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abciximab and angiographic restenosis af

Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT—A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel

✍ Helmut Schühlen; Adnan Kastrati; Julinda Mehilli; Jörg Hausleiter; Josef Dirschi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Efficacy of Short-Term High-Dose Atorvas

Efficacy of Short-Term High-Dose Atorvastatin Pretreatment in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Nine Randomized Controlled Trials

✍ Liu, Yangchun; Su, Qiang; Li, Lang 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

878-3 Subgroup analysis of the impact of

878-3 Subgroup analysis of the impact of the glycoprotein IIb/IIIa inhibitor abciximab in patients undergoing elective stent placement >2 hours after treatment with a 600 milligram loading dose of clopidogrel: Results from the ISAR REACT trial

✍ Peter B Berger; Adnan Kastrati; Julinda Mehilli; Helmut Schuhlen; Josef Dirschin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

TCT-120: Effectiveness of Bivalirudin Th

TCT-120: Effectiveness of Bivalirudin Therapy in Patients With High Residual Platelet Activity After Clopidogrel Loading Dose in Patients Undergoing Elective Percutanous Coronary Intervention: Six-month Results from the Antithrombotic Regimens aNd Outcome (ARNO) Trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 82 KB